• Ogawa, A., Izumikawa, K., Tate, S., Isoyama, S., Mori, M., Fujiwara, K., Watanabe, S., Ohga, T., Jo, U., Taniyama, D., Kitajima, S., Tanaka, S., Onji, H., Kageyama, S.-I., Yamamoto, G., Saito, H., Morita, T. Y., Okada, M., Natsumeda, M., Nagahama, M., Kobayashi, J., Ohashi, A., Sasanuma, H., Higashiyama, S., Dan, S., Pommier, Y. and Murai, J.
  SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis.
  Mol. Cell, in press (2025)
• Utsumi, T., Mizuta, H., Seto, Y., Uchibori, K., Nishio, M., Okamoto, I. and Katayama, R.
  AXL-mediated drug resistance in ALK-rearranged NSCLC enhanced by GAS6 from macrophages and MMP11 positive fibroblasts.
  Cancer Sci., in press (2025)
• Maruyama, K., Shimizu, Y., Nomura, Y., Oh-hara, T., Takahashi, Y., Nagayama, S., Fujita, N. and Katayama, R.
  Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization.
  npj Precis Oncol, in press (2025)
• Sasaki, N., Homme, M., Murayama, T., Osaki, T., Tenma, T., An, T., Takegami, Y., Tani, T., Gedeon, P. C., Kobayashi, Y., Cañadas, I., Barbie, D. A., Yao, R. and Kitajima, S.
  RNA sensing induced by chromosome missegregation augments anti-tumor immunity.
  Mol. Cell, in press (2024)
• Fujimura, T., Furugaki, K., Mizuta, H., Muraoka, S., Nishio, M., Adachi, J., Uchibori, K., Miyauchi, E., Hayashi, H., Katayama, R. and Yoshiura, S.
  Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer.
  NPJ Precis. Oncol., 264, in press (2024)
  
  

more